Nuveen LLC Makes New $11.60 Million Investment in Azenta, Inc. $AZTA

Nuveen LLC purchased a new position in Azenta, Inc. (NASDAQ:AZTA) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 335,002 shares of the company’s stock, valued at approximately $11,604,000. Nuveen LLC owned approximately 0.73% of Azenta as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Aigen Investment Management LP purchased a new stake in Azenta in the 1st quarter worth $327,000. Invesco Ltd. lifted its stake in Azenta by 1.3% in the 1st quarter. Invesco Ltd. now owns 221,728 shares of the company’s stock worth $7,681,000 after purchasing an additional 2,933 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Azenta in the 1st quarter worth $1,338,000. Zions Bancorporation National Association UT purchased a new stake in Azenta in the 1st quarter worth $1,034,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Azenta by 8.9% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,842 shares of the company’s stock worth $168,000 after purchasing an additional 396 shares in the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on AZTA shares. Stephens started coverage on shares of Azenta in a report on Tuesday, July 22nd. They issued an “equal weight” rating and a $35.00 target price on the stock. Needham & Company LLC reduced their target price on shares of Azenta from $59.00 to $40.00 and set a “buy” rating on the stock in a report on Wednesday, May 7th. Evercore ISI set a $33.00 target price on shares of Azenta and gave the stock an “in-line” rating in a report on Tuesday, August 5th. Finally, Raymond James Financial upgraded shares of Azenta from a “market perform” rating to an “outperform” rating and set a $35.00 target price on the stock in a report on Wednesday, August 6th. Two investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Azenta presently has a consensus rating of “Hold” and a consensus price target of $35.75.

Azenta Trading Up 5.7%

Shares of NASDAQ:AZTA opened at $31.55 on Friday. The company has a market capitalization of $1.45 billion, a price-to-earnings ratio of -13.04 and a beta of 1.59. Azenta, Inc. has a 12 month low of $23.91 and a 12 month high of $55.63. The firm’s 50-day moving average is $31.32 and its 200 day moving average is $32.86.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.13 by $0.06. The company had revenue of $143.94 million for the quarter, compared to the consensus estimate of $149.64 million. Azenta had a negative net margin of 18.45% and a positive return on equity of 1.35%. The firm’s revenue was up .0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.14 EPS. As a group, equities analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.